Measuring the importance of different barriers to opioid agonist treatment using best-worst scaling in an Australian setting

Natasha Yvonne Hall, Long Le, Julie Abimanyi-Ochom and Cathy Mihalopoulos

Health Policy, 2023, vol. 138, issue C

Abstract: Opioid agonist treatment (OAT) is an effective treatment for opioid use disorder (OUD), however several client barriers to OAT are reported. Client importance of these barriers using economic preference elicitation measures have not been identified. This paper determines the most important OAT barriers using best-worst scaling (BWS) and compares the results of BWS to Likert scale.

Keywords: Opioid agonist treatment; Barriers to treatment; Heroin dependence; Prescription opioid dependence; Opioid use disorder; Likert scale; Best-worst scale; Needle syringe sites (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851023002245
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:138:y:2023:i:c:s0168851023002245

DOI: 10.1016/j.healthpol.2023.104939

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().